Cat. No.: DIA-0230092
Product Information | |
---|---|
CAS No. | 61276-17-3 |
Chemical Name | [(2R,3R,4R,5R,6R)-6-[2-(3,4-dihydroxyphenyl)ethoxy]-5-hydroxy-2-(hydroxymethyl)-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate |
Formula | C29H36O15 |
Molecular Weight | 624.59 |
PubChem CID | 5281800 |
SMILES | CC1C(C(C(C(O1)OC2C(C(OC(C2OC(=O)C=CC3=CC(=C(C=C3)O)O)CO)OCCC4=CC(=C(C=C4)O)O)O)O)O)O |
Target | PKC |
Product Description | PKC inhibitor. NF-κB inhibitor. |
Format & Storage | |
---|---|
Purity | > 98% |
Source | Synthetic |
Shipping | Shipped on dry ice. |
Storage | Store at Room Temperature. The product can be stored for up to 12 months. |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.